SC 13D/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)*

 

 

Tesaro, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

881569 10 7

(CUSIP Number)

W. STEPHEN HOLMES III

INTERWEST PARTNERS

2710 SAND HILL ROAD, SUITE 200

MENLO PARK, CALIFORNIA 94025

TELEPHONE: (650) 854-8585

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

January 12, 2015

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

InterWest Partners X, L.P.

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

California, United States of America    

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

0    

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock (2)    

     9.   

Sole Dispositive Power

 

0    

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock (2)    

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,881,701 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

PN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by InterWest Partners X, L.P. (“InterWest X”), InterWest Management Partners X, LLC (“IMP X,” together with InterWest X, the “InterWest Entities”), Philip T. Gianos (“Gianos”), W. Stephen Holmes III (“Holmes”), Nina Kjellson (“Kjellson”), Gilbert H. Kliman (“Kliman”), Arnold L. Oronsky (“Oronsky”), Douglas A. Pepper (“Pepper”), Bruce A. Cleveland (“Cleveland”), Khaled A. Nasr (“Nasr”) and Keval Desai (“Desai”). Together with the InterWest Entities, Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland, Nasr and Desai are herein collectively referred to as the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) The shares are owned by InterWest X, and include (i) 1,871,701 shares of Common Stock and (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Securities and Exchange Commission (the “Commission”) on November 6, 2014.

 

2.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

InterWest Management Partners X, LLC

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

California, United States of America    

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

0    

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock (2)    

     9.   

Sole Dispositive Power

 

0    

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock (2)    

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,881,701 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

OO    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) The shares are owned by InterWest X, and include (i) 1,871,701 shares of Common Stock and (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

3.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

Bruce A. Cleveland

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

60 shares of Common Stock

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock

     9.   

Sole Dispositive Power

 

60 shares of Common Stock

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,881,761 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)

14.  

Type of Reporting Person (see instructions)

 

IN

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 60 shares of Common Stock held by Cleveland. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

4.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

Philip T. Gianos

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

332 shares of Common Stock

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock

     9.   

Sole Dispositive Power

 

332 shares of Common Stock

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,882,033 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

IN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 332 shares of Common Stock held by Gianos. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

5.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

W. Stephen Holmes III

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

992 shares of Common Stock

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock

     9.   

Sole Dispositive Power

 

992 shares of Common Stock

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,882,693 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

IN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 992 shares of Common Stock held by Holmes. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

6.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

Nina S. Kjellson

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

654 shares of Common Stock

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock

     9.   

Sole Dispositive Power

 

654 shares of Common Stock

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,882,355 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

IN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 654 shares of Common Stock held by Kjellson. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

7.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

Gilbert H. Kliman

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

1,263 shares of Common Stock    

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock     

     9.   

Sole Dispositive Power

 

1,263 shares of Common Stock    

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock     

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,882,964 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

IN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 1,263 shares of Common Stock held by Kliman. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

8.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

Khaled A. Nasr

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America    

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

360 shares of Common Stock    

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock     

     9.   

Sole Dispositive Power

 

360 shares of Common Stock    

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock     

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,882,061 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

IN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 360 shares of Common Stock held by Nasr. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

9.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

Arnold L. Oronsky

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America    

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

9,093 shares of Common Stock (2)    

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock     

     9.   

Sole Dispositive Power

 

9,093 shares of Common Stock (2)    

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock     

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,890,794 shares of Common Stock (3)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

IN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes 6,614 shares of Common Stock held directly by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X.
(3) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 9,093 shares of Common Stock held by Oronsky, of which 6,614 shares of Common Stock are held directly by Oronsky for the benefit of InterWest X. As of 60 days from the date of this Amendment No. 2, Mr. Oronsky has the right to exercise the option with respect to 10,000 shares. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(4) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

10.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

Douglas A. Pepper

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

60 shares of Common Stock

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock

     9.   

Sole Dispositive Power

 

60 shares of Common Stock

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,881,761 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

IN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 60 shares of Common Stock held by Pepper. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

11.


13D/A

 

CUSIP No. 881569 10 7  

 

  1.   

Name of Reporting Persons

 

Keval Desai

  2.  

Check the Appropriate Box if a Member of a Group (see instructions)

 

(a)  ¨        (b)  x(1)

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (see instructions)

 

WC    

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)

 

¨    

  6.  

Citizenship or Place of Organization

 

United States of America

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

 

     7.    

Sole Voting Power

 

240 shares of Common Stock

     8.   

Shared Voting Power

 

1,881,701 shares of Common Stock

     9.   

Sole Dispositive Power

 

240 shares of Common Stock

   10.   

Shared Dispositive Power

 

1,881,701 shares of Common Stock

11.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,881,941 shares of Common Stock (2)

12.  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (see instructions)

 

¨    

13.  

Percent of Class Represented by Amount in Row 11

 

5.2% (3)    

14.  

Type of Reporting Person (see instructions)

 

IN    

 

(1) This Amendment No. 2 to the statement on Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes (i) 1,871,701 shares of Common Stock held by InterWest X, (ii) 10,000 shares of Common Stock underlying a stock option held by Oronsky (in connection with Oronsky’s service as a director of the Issuer) for the benefit of InterWest X exercisable within 60 days of the date of this filing, and (iii) 360 shares of Common Stock held by Desai. IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

 

12.


Explanatory Note

This Amendment No. 2 (the “Amendment”) to the statement on Schedule 13D is being filed by the Reporting Persons (as defined below) and amends and restates the Schedule 13D/A filed with the Commission on August 9, 2013 (the “Amended Schedule 13D”), and relates to shares of Common Stock, $0.0001 par value per share (“Common Stock”), of Tesaro, Inc., a Delaware corporation (the “Issuer”). This Amendment is being filed by the Reporting Persons to report the distribution of shares of Common Stock of the Issuer on January 12, 2015. Accordingly, the number of securities beneficially owned by the Reporting Persons has decreased.

Items 2, 4, 5 and 7 of the Amended Schedule 13D are hereby amended and supplemented to the extent hereinafter expressly set forth and, except as amended and supplemented hereby, the Amended Schedule 13D remains in full force and effect. All capitalized terms used in this Amendment but not defined herein shall have the meanings ascribed thereto in the Amended Schedule 13D.

Item 2. Identity and Background

Schedule 1 of the Amended Schedule 13D is hereby amended and restated in its entirety by Schedule 1 hereto.

Item 4. Purpose of Transaction

Item 4 of the Amended Schedule 13D is hereby amended and supplemented by adding the following paragraph at the end of Item 4:

On January 12, 2015, the Reporting Persons distributed in kind an aggregate of 600,000 shares of Common Stock held by the Reporting Persons on a pro rata basis to their respective partners and members.

Item 5. Interest in Securities of the Issuer

Item 5 of the Amended Schedule 13D is hereby amended and restated in its entirety as follows:

(a)(b) The following information with respect to the ownership of the Common Stock of the Issuer by the Reporting Persons filing this Statement on Schedule 13D is provided as of the date of this filing:

 

Reporting Persons   

Shares

Held

Directly (1)

    

Sole

Voting

Power (1)

    

Shared

Voting

Power (1)

    

Sole

Dispositive

Power (1)

    

Shared

Dispositive

Power (1)

    

Beneficial

Ownership (1)

    

Percentage of

Class (1, 3)

 

InterWest X

     1,881,701         0         1,881,701         0         1,881,701         1,881,701         5.2

IMP X (2)

     0         0         1,881,701         0         1,881,701         1,881,701         5.2

Gianos (2)

     332         332         1,881,701         332         1,881,701         1,882,033         5.2

Holmes (2)

     992         992         1,881,701         992         1,881,701         1,882,693         5.2

Kjellson (2)

     654         654         1,881,701         654         1,881,701         1,882,355         5.2

Kliman (2)

     1,263         1,263         1,881,701         1,263         1,881,701         1,882,964         5.2

Oronsky (2)

     9,093         9,093         1,881,701         9,093         1,881,701         1,890,794         5.2

Pepper (2)

     60         60         1,881,701         60         1,881,701         1,881,761         5.2

Cleveland (2)

     60         60         1,881,701         60         1,881,701         1,881,761         5.2

Nasr (2)

     360         360         1,881,701         360         1,881,701         1,882,061         5.2

Desai (2)

     240         240         1,881,701         240         1,881,701         1,881,941         5.2

 

(1) Represents the number of shares of Common Stock currently underlying all Securities held by the Reporting Persons.

 

13.


(2) IMP X serves as the general partner of InterWest X. Gianos, Holmes, Kjellson, Kliman, Oronsky, Pepper, Cleveland are Managing Directors of IMP X, and Nasr and Desai are Venture Members of IMP X and share voting and dispositive power over the shares held by InterWest X, and may be deemed to own beneficially the shares held by InterWest X.
(3) This percentage set forth on the cover sheets is calculated based on 36,061,589 shares of the Issuer’s Common Stock outstanding as of October 30, 2014, as disclosed in the Issuer’s Form 10-Q, filed with the Commission on November 6, 2014.

(c) On January 12, 2015, the Reporting Persons distributed in kind the following shares of Common Stock on a pro rata basis to their respective partners and members:

 

Reporting Person(s)

   Number of
Shares Distributed
 

InterWest X

     594,000   

IMP X

     6,000   
  

 

 

 

Total:

     600,000   
  

 

 

 

By virtue of the foregoing distributions, the following Reporting Persons received an aggregate of 4,159 shares of Common Stock:

 

Reporting Person(s)

   Number of
Shares Distributed
 

Cleveland

     60   

Desai

     120   

Gianos

     172   

Holmes

     505   

Kjellson

     536   

Kliman

     1263   

Nasr

     180   

Oronsky

     1,263   

Pepper

     60   

Non-voting Members

     1,841   
  

 

 

 

Total:

     6,000   
  

 

 

 

Item 7. Material to Be Filed as Exhibits

A. Agreement regarding filing of joint Schedule 13D/A

 

14.


SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: January 23, 2015

INTERWEST PARTNERS X, L.P.

 

By: InterWest Management Partners X, LLC
Its: General Partner
By:  

/s/ W. Stephen Holmes III

  W. STEPHEN HOLMES III
  Managing Director
INTERWEST MANAGEMENT PARTNERS X, LLC
By:  

/s/ W. Stephen Holmes III

  W. STEPHEN HOLMES III
  Managing Director

 

/s/ Karen A. Wilson

Karen A. Wilson, Attorney-in-Fact for Philip T. Gianos

/s/ W. Stephen Holmes III

W. Stephen Holmes III

/s/ Karen A. Wilson

Karen A. Wilson, Attorney-in-Fact for Nina Kjellson

/s/ Karen A. Wilson

Karen A. Wilson, Attorney-in-Fact for Gilbert H. Kliman

/s/ Karen A. Wilson

Karen A. Wilson, Attorney-in-Fact for Arnold L. Oronsky

/s/ Karen A. Wilson

Karen A. Wilson, Attorney-in-Fact for Douglas A. Pepper

/s/ Karen A. Wilson

Karen A. Wilson, Attorney-in-Fact for Bruce A. Cleveland

/s/ Karen A. Wilson

Karen A. Wilson, Attorney-in-Fact for Khaled A. Nasr

/s/ Karen A. Wilson

Karen A. Wilson, Attorney-in-Fact for Keval Desai

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Attention: Intentional misstatements or omissions of fact

constitute Federal criminal violations (See 18 U.S.C. 1001)

 

15.


SCHEDULE I

Managers:

Philip T. Gianos

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Managing Director of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

W. Stephen Holmes III

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Managing Director of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

Nina S. Kjellson

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Managing Director of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

Gilbert H. Kliman

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Managing Director of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

Arnold L. Oronsky

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Managing Director of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

Douglas A. Pepper

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Managing Director of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

Bruce A. Cleveland

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Managing Director of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

Venture Members:

Khaled A. Nasr

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Venture Member of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

 

16.


Keval Desai

c/o InterWest Partners

2710 Sand Hill Road, Suite 200

Menlo Park, California 94025

Principal Occupation: Venture Member of IMP X, which serves as the general partner of InterWest X

Citizenship: United States of America

 

17.


EXHIBIT INDEX

 

A. Agreement regarding filing of joint Schedule 13D/A

 

18.